Purchase $70 million worth of financial products from REMEGEN (09995).
Rongchang Biology (09995) announced that on May 14, 2026, the company entered into a wealth management product agreement with Oversea-Chinese Banking Corporation Limited (OCBC Bank), whereby the company agreed to purchase wealth management products from OCBC Bank using 70 million US dollars of idle funds.
REMEGEN (09995) announced that on May 14, 2026, the company entered into a wealth management product agreement with OCBC Bank. According to the agreement, the company agrees to purchase wealth management products from OCBC Bank with USD 70 million of idle funds.
Related Articles
MADISON HLDG(08057): The share consolidation will take effect from May 18th.
Eastroc Beverage(09980): Chengdu base signed the "State-owned construction land use right transfer contract" with the Planning and Natural Resources Bureau of Wenjiang District, Chengdu City.
On May 14, TRADEGO (08017) spent 1.2473 million Hong Kong dollars to repurchase 1 million shares.
MADISON HLDG(08057): The share consolidation will take effect from May 18th.
Eastroc Beverage(09980): Chengdu base signed the "State-owned construction land use right transfer contract" with the Planning and Natural Resources Bureau of Wenjiang District, Chengdu City.
On May 14, TRADEGO (08017) spent 1.2473 million Hong Kong dollars to repurchase 1 million shares.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
